130 related articles for article (PubMed ID: 12930045)
1. Outcomes of diabetes care: a population-based study.
Färnkvist LM; Lundman BM
Int J Qual Health Care; 2003 Aug; 15(4):301-7. PubMed ID: 12930045
[TBL] [Abstract][Full Text] [Related]
2. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetes, epidemiological characteristics and vascular complications.
Russo MP; Grande-Ratti MF; Burgos MA; Molaro AA; Bonella MB
Arch Cardiol Mex; 2023; 93(1):30-36. PubMed ID: 36757785
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of macrovascular complications in diabetics of WAH, District Rawalpindi.
Hashim R; Khan FA; Khan DA; Shaukat A
J Pak Med Assoc; 1999 Jan; 49(1):8-11. PubMed ID: 10463008
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
De Pablos PL; Martinez J; Martinez MP; Doreste JA
Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644
[TBL] [Abstract][Full Text] [Related]
6. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].
Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A
Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612
[TBL] [Abstract][Full Text] [Related]
7. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
Pittrow D; Stalla GK; Zeiher AM; Silber S; März W; Pieper L; Klotsche J; Glaesmer H; Ruf G; Schneider HJ; Lehnert H; Böhler S; Koch U; Wittchen HU
Med Klin (Munich); 2006 Aug; 101(8):635-44. PubMed ID: 16896570
[TBL] [Abstract][Full Text] [Related]
10. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
11. Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis.
Kar D; Gillies C; Zaccardi F; Webb D; Seidu S; Tesfaye S; Davies M; Khunti K
Cardiovasc Diabetol; 2016 Nov; 15(1):158. PubMed ID: 27881170
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and peripheral vascular disease.
Huysman E; Mathieu C
Acta Chir Belg; 2009 Oct; 109(5):587-94. PubMed ID: 19994800
[TBL] [Abstract][Full Text] [Related]
13. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
Chaturvedi N; Stephenson JM; Fuller JH
Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
[TBL] [Abstract][Full Text] [Related]
14. Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional study.
Wang L; Xing Y; Yu X; Ming J; Liu X; Li X; Fu J; Zhou J; Gao B; Hu D; Pan C; Ji L; Ji Q
J Diabetes Investig; 2020 Sep; 11(5):1285-1294. PubMed ID: 32227466
[TBL] [Abstract][Full Text] [Related]
15. Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.
Zhao L; Ma J; Wang S; Xie Y
Diabetes Technol Ther; 2015 Jan; 17(1):29-34. PubMed ID: 25574593
[TBL] [Abstract][Full Text] [Related]
16. Overweight, obesity and chronic complications of diabetes mellitus in patients attending Diabetic Centre, Teaching Hospital, Jaffna, Sri Lanka.
Sujanitha V; Sivansuthan S; Selvakaran P; Parameswaran P
Ceylon Med J; 2015 Sep; 60(3):94-6. PubMed ID: 26520862
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
[TBL] [Abstract][Full Text] [Related]
18. Physician and patient prevention practices in NIDDM in a large urban managed-care organization.
Martin TL; Selby JV; Zhang D
Diabetes Care; 1995 Aug; 18(8):1124-32. PubMed ID: 7587847
[TBL] [Abstract][Full Text] [Related]
19. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.
Olsen BS; Johannesen J; Sjølie AK; Borch-Johnsen K; Hougarrdss P; Thorsteinsson B; Prammingss S; Marinelli K; Mortensen HB
Diabet Med; 1999 Jan; 16(1):79-85. PubMed ID: 10229298
[TBL] [Abstract][Full Text] [Related]
20. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin.
Helliwell R; Warnes H; Kietsiriroje N; Campbell M; Birch R; Pearson SM; Ajjan RA
Diabet Med; 2021 May; 38(5):e14529. PubMed ID: 33502032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
